Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D1/3-MAGE3-HIS Fusion Protein with Adjuvant SBAS02B in Stage IV Melanoma
NCT00042783Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2002
- Modality
- Vaccines & Immunotherapeutics, Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of astuprotimut-R in melanoma, sponsored by SWOG Cancer Research Network. Started Sep 2002; status: completed.
02
Drugs
astuprotimut-R
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00042783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042783.